CXCL1 and gout: Another recent report in gout showed that the HGF/MET pathway blockade in a model of MSU-induced arthritis resolved articular inflammation, tissue damage, and joint pain by enhancing neutrophilic apoptosis and reducing neutrophil infiltration, as well as decreasing CXCL1.77